AXIM® Biotechnologies Commences Commercial Manufacturing of FDA-Cleared Proprietary Ocular Diagnostic Assays
April 11, 2023 09:00 ET
|
AXIM Biotechnologies, Inc.
Leading Diagnostic Healthcare Company Begins Manufacturing of Ocular Immunoglobulin (IgE), Lactoferrin Tests to Fulfill Orders From Commercialization Partner SAN DIEGO, CA, April 11, 2023 ...
Akari Therapeutics to Attend ARVO 2023, the Annual Meeting of The Association for Research in Vision and Ophthalmology
April 11, 2023 08:00 ET
|
Akari Therapeutics Plc
NEW YORK and LONDON, April 11, 2023 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory...
Atsena Therapeutics Announces Six-Month Data from Phase I/II Clinical Trial of ATSN-101 to be Presented at ARVO 2023 Annual Meeting
April 11, 2023 07:30 ET
|
Atsena Therapeutics
DURHAM, N.C., April 11, 2023 (GLOBE NEWSWIRE) -- Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent...
ONL Therapeutics to Report Clinical Data on ONL1204 in Podium Presentation at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
April 11, 2023 07:00 ET
|
ONL Therapeutics
Presentation will review the results of ONL’s Phase 1 study of ONL1204 Ophthalmic Solution in patients with Macula-Off Rhegmatogenous Retinal Detachment Preclinical data in models of inherited...
Abeona Therapeutics Announces Multiple Abstracts Accepted from its AAV Ophthalmology Program at the 26th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
April 10, 2023 07:30 ET
|
Abeona Therapeutics Inc.
CLEVELAND, April 10, 2023 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the acceptance of three abstracts at the 26th Annual Meeting of the American Society of Gene...
Blepharoplasty Market size to reach USD 7.6 Mn by 2029 at a CAGR of 8.5 percent – says Maximize Market Research
April 07, 2023 09:08 ET
|
MAXIMIZE MARKET RESEARCH PRIVATE LIMITED
Pune, April 07, 2023 (GLOBE NEWSWIRE) -- A global Healthcare business consulting firm, Maximize Market Research, has published a market intelligence and competitive landscape report on the...
Endogena Therapeutics Completes Dose Escalation in the Phase 1/2a Clinical Trial of EA-2353 for the Treatment of Retinitis Pigmentosa
April 05, 2023 07:20 ET
|
Endogena
SAN FRANCISCO and TORONTO and ZÜRICH, Switzerland, April 05, 2023 (GLOBE NEWSWIRE) -- Endogena Therapeutics Inc., a clinical-stage biotech company focused on the development of endogenous...
Global Laser Technology Market is likely to witness a revenue of US$ 35.4 Billion at a high CAGR of 7.8% during the forecast period between 2022 and 2032 | Analysis by Future Market Insights, Inc.
April 03, 2023 20:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
DUBAI, United Arab Emirates, April 03, 2023 (GLOBE NEWSWIRE) -- The global laser technology market reached US$ 16.7 billion in 2022. Total sales in the market will clock at 7.8% from 2022 to 2032....
Ashvattha Therapeutics to Present Preclinical Data at the AACR and ARVO 2023 Annual Meetings
April 03, 2023 08:30 ET
|
Ashvattha Therapeutics
Preclinical data to be presented at AACR will showcase the potential effect of D-4559, a potent macrophage switching nanomedicine, on reducing tumor growth in a mouse model of hepatocellular...
Théa Open Innovation and Galimedix announce strategic partnership to develop and commercialize GAL-101, a Phase 2/3-ready small molecule, to treat ophthalmic indications with high unmet medical need
March 29, 2023 08:00 ET
|
Galimedix Therapeutics, Inc.
Galimedix eligible for upfront payment plus various success-based milestone payments and royalties on future net salesEquity investment by Théa Open Innovation into Galimedix supports further...